Baxter Pharma
Pharmaceutical and Medicine Manufacturing Industry.
QC Lab turnkey and construction management.
7136.47sqft
March 2020
Completed
Gujarat, India
Ground
4m
Rs. 2.25 Cr.
Baxter Pharmaceuticals India Private Limited, BPIPL, is a Ahmedabad-based generic injectables facility.
They formulate, fill and finish a broad portfolio of essential generic medicines with complementary strengths in anaesthesia and analgesics, critical care and renal medicines, and anti-infectives in a variety of presentations including bags, vials and ampules.
Bio Equivalence Centre
Bio equivalence centre
QC Lab turnkey and construction management.
Gold
18,700 Sq. Ft.
June 2020
Completed
Bengaluru, India
Ground
5m
Rs. 248 Cr.
The plant locational advantages regarding the infrastructural facilities like power, water, and roads are fully developed and connected to National Highways. This is well connected to National Highways and Airports for Domestic and International Market.
Apotex Research Private Limited., is a Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world. The plant is proposed to construct in about 90 acres of land.
Apotex is comprised of multiple divisions and affiliates:
Facelift of R&D Blocks
Bio Pharma Production &Research facility.
QC Lab turnkey and construction management.
Silver
3,63,100 Sq.Mts.
Rs. 248 Cr.
July 2019
Ongoing
Turkapally, India
Ground+2
12m
Gold
Block 2-1440 Sq. Mts.
Block 3-1375 Sq. Mts
Block 4-1435 Sq. Mts.
Total - 4250 Sq. Mts.
The plant locational advantages regarding the infrastructural facilities like power, water, and roads are fully developed and connected to National Highways. This is well connected to National Highways and Airports for Domestic and International Market.
Sai Life Sciences Ltd., is one of India’s fastest growing Contract Research, Development & Manufacturing Organizations that engage in the discovery, development, and commercialisation of NCE small molecule programmes.
The plant is proposed to construct in about 90 acres of land.
The company is engaged in activities related to in-vitro, in-vivo, DMPK & Toxicology.
The in-vitro facilities offered are:
The in-vivo facilities offered are
DMPK facilities include
Toxicology
Star Project
Bio Pharma Production &Research facility
QC Lab turnkey and construction management.
3,63,100 Sq.Mts.
29,620 Sq Ft.
Gold
March 2021
Completed
Bengaluru, India
Third
12m
Rs. 248 Cr.
The plant locational advantages regarding the infrastructural facilities like power, water, and roads are fully developed and connected to National Highways. This is well connected to National Highways and Airports for Domestic and International Market.
Syngene International Ltd., is an integrated research, development, and manufacturing organization providing services from early discovery and development to commercial manufacturing for small and large molecules.
The plant is proposed to construct in about 90 acres of land.
The company is engaged in activities from pre-clinical to clinical trials, including drug substance and drug product development, and associated services to demonstrate the safety, tolerability, and
efficacy of the selected drug candidate, cGMP compliant manufacturing of clinical supplies, and registration batches for small molecules.
Manufacturing of small and large molecules for commercial supplies through cGMP compliant facilities, a state-of heart API manufacturing campus and a biologics manufacturing facility is also carried out here.